Scientific misconduct in the pharmaceutical industry
Publication date
2013-01-15
Authors
Hoogendoorn, Marie-Louise
Lange, Anouk De
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
In the area of pharmaceutical research, misconduct has become a well-known phenomenon that has many different determinants. Developing a drug costs pharmaceutical companies a lot of money. The investing industries and academic institutions seem to have a financial conflict of interest. For example, when researchers and the media eventually discovered that some patients who took Prozac experience serious side effects (even suicide) the drug was already popular and doctors continued to write prescriptions. This is an issue that should be taken seriously because this involves human lives.
Keywords
pharmaceutical companies, Prozac, pharmaceutical misconduct, drug costs financial conflict of interest.